Search Results - "Flores, Eva Iglesias"

Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents by Guasch, Montserrat, Cañete, Fiorella, Ordás, Ingrid, Iglesias‐Flores, Eva, Clos, Ariadna, Gisbert, Javier P., Taxonera, Carlos, Vera, Isabel, Mínguez, Miguel, Guardiola, Jordi, Rivero, Montserrat, Nos, Pilar, Gomollón, Fernando, Barrio, Jesús, Francisco, Ruth, López‐Sanromán, Antonio, Martín‐Arranz, M. Dolores, Garcia‐Planella, Esther, Camargo, Raquel, García‐López, Santiago, Castro, Luisa, Calvet, Xavier, Esteve, Maria, Mañosa, Míriam, Domènech, Eugeni

“…Background and Aim Biological therapies may be changing the natural history of inflammatory bowel diseases (IBDs), reducing the need for surgical intervention…”
Get full text

Role of serum cytokine profile in ulcerative colitis assessment by Rodríguez‐Perlvárez, Manuel Luis, García‐Sánchez, Valle, Villar‐Pastor, Carlos Manuel, González, Raál, Iglesias‐Flores, Eva, Muntane, Jordi, Gómez‐Camacho, Federico

“…Background: Several cytokines are overexpressed in the colonic mucosa of patients with ulcerative colitis (UC). The measurement of these parameters in plasma…”
Get full text

Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection by García‐Sánchez, María del Valle, Gómez‐Camacho, Federico, Poyato‐González, Antonio, Iglesias‐Flores, Eva María, de Dios‐Vega, Juan Francisco, Sancho‐Zapatero, Rocio

Get full text

Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs by Medina-Medina, Rosario, Iglesias-Flores, Eva, Benítez, Jose M, Marín-Pedrosa, Sandra, Salgueiro-Rodríguez, Isabel, Linares, Clara I, González-Rubio, Sandra, Soto-Escribano, Pilar, Gros, Beatriz, Rodríguez-Perálvarez, Manuel L, Cabriada, José L, Chaparro, María, Gisbert, Javier P, Chicano-Gálvez, Eduardo, Ortea, Ignacio, Ferrín, Gustavo, García-Sánchez, Valle, Aguilar-Melero, Patricia

“…Therapy with anti-tumor necrosis factor (TNF) has dramatically changed the natural history of Crohn's disease (CD). However, these drugs are not without…”
Get full text

Mesalazine induced interstitial pneumonitis in the COVID era by Aparicio Serrano, Ana, Gallego Jiménez, Elma, Castro Rodríguez, Javier, Soto Escribano, Pilar, Iglesias Flores, Eva, Marín Pedrosa, Sandra, Benítez, José Manuel

“…Mesalazine is the most widely used aminosalicylate for induction and maintenance of remission in patients with mild-to-moderate ulcerative colitis (UC)…”
Get full text

Bile acid malabsorption in patients with chronic diarrhea and Crohn's disease by Mena Bares, Luisa M ª, Benítez Cantero, José M, Iglesias Flores, Eva, Gros Alcalde, Beatriz, Moreno Ortega, Estefanía, Maza Muret, Francisco R, Carmona Asenjo, Elvira, García Sánchez, M ª Valle, Vallejo Casas, Juan A

“…Crohn's disease (CD) is a form of inflammatory bowel disease and is mainly characterized by diarrhea and abdominal pain. The aim of our study was to analyze…”
Get full text

Adequate rate of response to hepatitis B virus vaccination in patients with inflammatory bowel disease by Vida Pérez, Luis, Gómez Camacho, Federico, García Sánchez, Valle, Iglesias Flores, Eva M A, Castillo Molina, Laura, Cerezo Ruiz, Antonio, Casáis Juanena, Luis, De Dios Vega, Juan Francisco

“…Patients with Inflammatory Bowel Disease (IBD) may have an increased risk of developing hepatitis B virus (HB) infection. Invasive procedures such as…”
Get more information

Adherence to a predefined vaccination program in patients with inflammatory bowel disease by Ruiz-Cuesta, Patricia, González-Alayón, Carlos, Jurado-García, Juan, Iglesias-Flores, Eva M, Barranco-Quintana, José L, García-García, Luisa, Salgueiro-Rodríguez, Isabel M, Benitez-Cantero, José M, García-Sánchez, Valle

“…The application of vaccination programs in patients with inflammatory bowel disease (IBD) is heterogeneous and generally deficient. As a result, adherence in…”
Get more information

Is safety infliximb during pregnancy in patients with inflammatory bowel disease? by Argüelles-Arias, Federico, Castro-Laria, Luisa, Barreiro-de Acosta, Manuel, García-Sánchez, Ma Valle, Guerrero-Jiménez, Pedro, Gómez-García, Ma Rosa, Cordero-Ruiz, Patricia, Iglesias-Flores, Eva, Gómez-Camacho, Federico, Domínguez-Muñoz, Enrique J, Herrerías-Gutiérrez, Juan Manuel

“…in most cases, inflammatory bowel disease (IBD) debuts at reproductive age. The data available in the literature show infliximab (IFX) to be a safe drug during…”
Get full text

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study by Chaparro, María, Baston-Rey, Iria, Fernández-Salgado, Estela, González García, Javier, Ramos, Laura, Diz-Lois Palomares, María Teresa, Argüelles-Arias, Federico, Iglesias Flores, Eva, Cabello, Mercedes, Rubio Iturria, Saioa, Núñez Ortiz, Andrea, Charro, Mara, Ginard, Daniel, Dueñas Sadornil, Carmen, Merino Ochoa, Olga, Busquets, David, Iyo, Eduardo, Gutiérrez Casbas, Ana, Ramírez de la Piscina, Patricia, Boscá-Watts, Marta Maia, Arroyo, Maite, García, María José, Hinojosa, Esther, Gordillo, Jordi, Martínez Montiel, Pilar, Velayos Jiménez, Benito, Quílez Ivorra, Cristina, Vázquez Morón, Juan María, María Huguet, José, González-Lama, Yago, Muñagorri Santos, Ana Isabel, Amo, Víctor Manuel, Martín-Arranz, María Dolores, Bermejo, Fernando, Martínez Cadilla, Jesús, Rubín de Célix, Cristina, Fradejas Salazar, Paola, San Román, Antonio López, Jiménez, Nuria, García López, Santiago, Figuerola, Anna, Jiménez, Itxaso, Martínez Cerezo, Francisco José, Taxonera, Carlos, Varela, Pilar, de Francisco, Ruth, Monfort, David, Molina Arriero, Gema, Hernández Camba, Alejandro, García-Alonso, Francisco Javier, Van Domselaar, Manuel, Pajares Villarroya, Ramón, Núñez, Alejandro, Rodríguez Moranta, Francisco, Marín-Jiménez, Ignacio, Robles Alonso, Virginia, Martín Rodríguez, María del Mar, Camo-Monterde, Patricia, García Tercero, Iván, Navarro Llavat, Mercedes, Arias García, Lara, Hervías Cruz, Daniel, Sulleiro, Sara, Novella, Cynthia, Vispo, Eugenia, Barreiro-de Acosta, Manuel, Gisbert, Javier P

“…Abstract Background Large real-world-evidence studies are required to confirm the durability of response, effectiveness, and safety of ustekinumab in Crohn’s…”
Get full text

Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry by Iborra, Marisa, Beltrán, Belén, Fernández‐Clotet, Agnes, Iglesias‐Flores, Eva, Navarro, Pablo, Rivero, Montserrat, Gutiérrez, Ana, Sierra‐Ausin, Mónica, Mesonero, Francisco, Ferreiro‐Iglesias, Rocío, Hinojosa, Joaquín, Calvet, Xavier, Sicilia, Beatriz, González‐Muñoza, Carlos, Antolín, Beatriz, González‐Vivo, María, Carbajo, Ana Y., García‐López, Santiago, Martín‐Cardona, Albert, Surís, Gerard, Martin‐Arranz, María Dolores, Francisco, Ruth, Cañete, Fiorella, Domènech, Eugeni, Nos, Pilar, Taxonera, C., Gomollón, F., Lorente, R., Rodríguez‐Lago, I., Forés‐Bosch, A., Bernardos, E., Ramos, L., Delgado‐Guillena, P., Hernández, A., Van Domselaar, M., Hervás, D., Casas‐Deza, D.

“…Summary Background Data on the long‐term administration of ustekinumab in recommended doses are limited. Aim To assess the real‐world, long‐term effectiveness…”
Get full text

Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry by Cañete, Fiorella, Mañosa, Míriam, Casanova, María José, González-Sueyro, Ramiro C, Barrio, Jesús, Bermejo, Fernando, Nos, Pilar, Iglesias-Flores, Eva, García-Planella, Esther, Pérez-Calle, José Lázaro, Vicente, Raquel, Vera, Maribel, Ramos, Laura, Rivero, Montserrat, De Francisco, Ruth, Montserrat, Antonia, Benítez, Olga, Navarro, Pablo, Taxonera, Carlos, Hinojosa, Esther, Márquez-Mosquera, Lucía, Navarro-Llavat, Mercé, Ramírez-de la Piscina, Patricia, Gomollón, Fernando, Rodríguez-Alonso, Lorena, Núñez-Alonso, Alejandro, Fernández-Salazar, Luis, Almela, Pedro, Ríos León, Raquel, De Castro, Luisa, Gisbert, Javier P, Ricart, Elena, Cabré, Eduard, Domènech, Eugeni

“…Abstract Background Anti–tumor necrosis factor agents (anti-TNFs) are efficacious at preventing the postoperative recurrence (POR) of Crohn disease, as…”
Get full text

Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial by Chaparro, María, Gordillo, Jordi, Domènech, Eugeni, Esteve, Maria, Barreiro-de Acosta, Manuel, Villoria, Albert, Iglesias-Flores, Eva, Blasi, Mercedes, Naves, Juan E., Benítez, Olga, Nieto, Laura, Calvet, Xavier, García-Sánchez, Valle, Villagrasa, José Ramón, Marin, Alicia C., Donday, María G., Abad-Santos, Francisco, Gisbert, Javier P.

“…To compare Engerix-B and Fendrix hepatitis B virus for primo vaccination in inflammatory bowel disease (IBD). Patients with IBD were randomized 1:1 to receive…”
Get full text

Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life by González Alayón, Carlos, Pedrajas Crespo, Carolina, Marín Pedrosa, Sandra, Benítez, José Manuel, Iglesias Flores, Eva, Salgueiro Rodríguez, Isabel, Medina Medina, Rosario, García-Sánchez, Valle

“…Iron deficiency without anaemia (IDWA) is commonly found in outpatients with inflammatory bowel disease (IBD) in an even higher proportion than anaemia…”
Get more information

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis? by García-Sánchez, Valle, Iglesias-Flores, Eva, González, Raúl, Gisbert, Javier P, Gallardo-Valverde, José María, González-Galilea, Angel, Naranjo-Rodríguez, Antonio, de Dios-Vega, Juan F, Muntané, Jordi, Gómez-Camacho, Federico

“…An evaluation is made of the utility of fecal calprotectin in predicting relapse in patients with inflammatory bowel disease (IBD). The possible differences in…”
Get full text

Mo1860 REAL-WORLD LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN CROHN'S DISEASE: RESULTS FROM THE ENEIDA REGISTRY by Iborra, Marisa, Beltran, Belen, Fernández-Clotet, Agnes, Flores, Eva Iglesias, Cortes, Pablo Navarro, Rivero, Montserrat, Gutiérrez, Ana, Sierra-Ausin, Monica, Mesonero, Francisco, Ferreiro, Rocio, Hinojosa, Joaquin, Calvet, Xavier, Sicilia, Beatriz, González-Muñosa, Carlos, Antolín, Beatriz, Gonzalez, Maria, López, Ana Y. Carbajo, García-López, Santiago, Cardona, Albert Martin, Surís, Gerard, Arranz, Maria Dolores A. Martín, De Francisco, Ruth M., Cañete, Fiorella, Samso, Carlos Taxonera, Gomollon, Fernando, Lorente, Rufo, Rodríguez-Lago, Iago, Fores-Bosh, Ana, Bernardos, Esther, Ramos, Laura, Delgado-Guillena, Pedro, Camba, Alejandro Hernandez, Van Domselaar, Manuel, Hervás, David, Domènech, Eugeni, Nos, Pilar

Get full text

Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry by Calafat, Margalida, Mañosa, Míriam, Ricart, Elena, Nos, Pilar, Iglesias-Flores, Eva, Vera, Isabel, López-Sanromán, Antonio, Guardiola, Jordi, Taxonera, Carlos, Mínguez, Miguel, Martín-Arranz, M Dolores, de Castro, Luisa, de Francisco, Ruth, Rivero, Montserrat, Garcia-Planella, Esther, Calvet, Xavier, García-López, Santiago, Márquez, Lucía, Gomollón, Fernando, Barrio, Jesús, Esteve, Maria, Muñoz, Fernándo, Gisbert, Javier P, Gutiérrez, Ana, Hinojosa, Joaquín, Argüelles-Arias, Federico, Busquets, David, Bujanda, Luís, Pérez-Calle, José L, Sicilia, Beatriz, Merino, Olga, Martínez, Pilar, Bermejo, Fernando, Lorente, Rufo, Barreiro-de Acosta, Manuel, Rodríguez, Cristina, Fe García-Sepulcre, Mariana, Monfort, David, Cañete, Fiorella, Domènech, Eugeni

“…Abstract Background and Aims Immunomediated adverse events [IAEs] are the most frequently reported infliximab [IFX]-related adverse events. Combination therapy…”
Get full text

Characteristics of inflammatory bowel disease in patients of Roma/Gypsy ethnicity. A case-control study by Cabré, Eduard, Mañosa, Míriam, Marín, Ignacio, Martín-Mateos, Rosa, Iglesias-Flores, Eva, Barreiro-de-Acosta, Manuel, Nos, Pilar, Busquets, David, Menchén, Luis A., López-Sanromán, Antonio, Domènech, Eugeni

“…Peculiarities of inflammatory bowel disease (IBD) have been explored in ethnic groups, such as Asians, Hispanics, and Afro-Americans, but not in other ethnic…”
Get full text

Mo1831 Evolution of the Incidence of Inflamatory Bowel Disease in the South of Spain in Two Periods by Chaaro, Dina, Cantero, Jose Manuel Benitez, Amarillo, Raúl Perea, Argüelles-Arias, Federico, Castro-Laría, L, Maldonado-Pérez, María Belén, García-Sánchez, Valle, Flores, Eva Iglesias, Roldan, Antonio Benitez, Caunedo-Álvarez, Angel

Get full text

Su1865 – Real-World Short-Term Effectivenes of Ustekinumab in Crohn’s Disease: Results from the Eneida Registry by Iborra, Marisa, Beltran, Belen, Fernández-Clotet, Agnes, Gutiérrez, Ana, Antolín, Beatriz, Huguet, José María, de Francisco, Ruth, Merino-Ochoa, Olga, Carpio, Daniel, García-López, Santiago, Mesonero, Francisco, Mínguez, Miguel, Ferreiro, Rocio, López, Ana Y. Carbajo, Rivero, Montserrat, Chaparro, María, Piñero-Pérez, M. Concepción, Miquel, David Monfort i, Bujanda, Luis, García-Sepulcre, Mariana Fe, Cardona, Albert Martin, Cañete, Fiorella, Taxonera, Carlos, Sierra-Ausin, Monica, Ferrer-Rosique, Juan A., Martín-Arranz, MD, González-Muñosa, Carlos, Marcos, Noemí Manceñido, Rodríguez-Lago, Iago, Flores, Eva Iglesias, Fores-Bosh, Ana, Navarro-Llavat, Merce, Calafat, Margalida, Madrigal-Domínguez, Rosa E., Ramos, Laura, Arroyo, Maite, Busquets, David, Lorente, Rufo, Sainz-Arnau, Empar, Camba, Alejandro Hernandez, Morales, Victor Jair, Paredes, Jose María, Van Domselaar, Manuel, Hervás, David, Cañada, Antonio, Nos, Pilar

Get full text